STX11 and hemophagocytic syndrome: Further studies have provided evidence for uncontrolled macrophage activation, cytopenia, hepatosplenomegaly, and elevated levels of multiple proinflammatory cytokines in the serum in FHL-4 patients, which cannot be accounted for by an exocytosis defect (55) and suggests other roles for STX11.